International Stem Cell (ISCO) Return on Equity (2016 - 2025)
Historic Return on Equity for International Stem Cell (ISCO) over the last 15 years, with Q3 2025 value amounting to 0.02%.
- International Stem Cell's Return on Equity fell 1500.0% to 0.02% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.02%, marking a year-over-year decrease of 1500.0%. This contributed to the annual value of 0.05% for FY2024, which is 1300.0% down from last year.
- Per International Stem Cell's latest filing, its Return on Equity stood at 0.02% for Q3 2025, which was down 1500.0% from 0.06% recorded in Q2 2025.
- In the past 5 years, International Stem Cell's Return on Equity ranged from a high of 0.67% in Q1 2021 and a low of 0.02% during Q3 2025
- In the last 5 years, International Stem Cell's Return on Equity had a median value of 0.17% in 2024 and averaged 0.23%.
- Per our database at Business Quant, International Stem Cell's Return on Equity plummeted by -9900bps in 2021 and then skyrocketed by 1600bps in 2024.
- Quarter analysis of 5 years shows International Stem Cell's Return on Equity stood at 0.46% in 2021, then tumbled by -85bps to 0.07% in 2022, then surged by 187bps to 0.2% in 2023, then crashed by -73bps to 0.05% in 2024, then plummeted by -72bps to 0.02% in 2025.
- Its last three reported values are 0.02% in Q3 2025, 0.06% for Q2 2025, and 0.06% during Q1 2025.